FOXO4-DRI

Description

FOXO4-DRI is a synthetic research peptide studied primarily for its potential role in cellular senescence and longevity-related biological pathways. It has been investigated for its interaction with the FOXO4 and p53 signaling pathway, an important area of research involving cellular aging, stress responses, and programmed cell death. Laboratory studies have explored FOXO4-DRI as a potential senolytic research compound, with particular interest in its ability to selectively influence senescent cells while providing insight into mechanisms associated with tissue function and age-related cellular changes. Researchers use FOXO4-DRI to better understand the molecular pathways connecting cellular senescence, regeneration, and healthy aging. This compound is intended exclusively for laboratory research and scientific use and is not approved for human or animal consumption, medical treatment, or diagnostic procedures.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.